MossRehab is one of five facilities around the U.S performing a clinical study of a device called ReStore, a wearable robotic technology that can allow stroke patients to walk effectively and efficiently. The device was developed by ReWalk Robotics, which developed the ReWalk, a motorized exoskeleton suit that enables patients with lower limb disabilities, including complete paralysis, to independently stand, walk, and—in some cases—climb stairs. The ReStore is aimed at providing similar assistance to stroke patients. 

“We are very excited to once again collaborate with ReWalk in the development of advanced technology to improve mobility in persons with impaired ambulation,” said MossRehab’s Chief Medical Officer Alberto Esquenazi, MD, who is one of the trial investigators. “We are very encouraged by our initial impressions on the positive impact of ReStore in gait training for persons with stroke residual disabilities.”

MossRehab launched the first clinical trials in the U.S. for ReWalk in 2009, and is proud to have played a part in development of the device, which has received approval from the Food and Drug Administration for use in hospitals and at home.

ReWalk hopes to make the ReStore device available for patients commercially in the first half of 2019.

Listen to a report on KYW radio about MossRehab and the ReStore device
Read more about ReStore in Orthopedic Design & Technology magazine
Learn more about ReWalk
Learn more about MossRehab's spinal cord injury services